Incyte Corporation (INCY) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Incyte Corporation
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF), polycythemia vera, and steroid-refractory acute…
Source: Yahoo Finance
Sector & Industry
Incyte Corporation operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Incyte Corporation at a Glance
| Company | Incyte Corporation |
| Ticker | INCY |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $126.75 |
| Market cap | $25.69B |
| P/E ratio (trailing) | 16.15 |
| EPS (trailing) | $7.85 |
| 52-week high | $132.60 |
| 52-week low | $81.09 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.77 |
| Return on equity (ROE) | 30.67% |
| Debt-to-equity | 0.60% |
| Average volume | 1.79M |
| Shares outstanding | 202.70M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 2,844 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is Incyte Corporation's current P/E ratio?
- Incyte Corporation (INCY) has a trailing P/E ratio of 16.15 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Incyte Corporation's market capitalisation?
- Incyte Corporation's market cap is $25.69B based on our latest snapshot. See how it ranks by market cap →
- What is INCY's 52-week range?
- Over the past 52 weeks, INCY has traded between $81.09 and $132.60. What does the 52-week range mean? →
- How volatile is Incyte Corporation compared to the market?
- Incyte Corporation has a beta of 0.77, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Incyte Corporation pay a dividend?
- Incyte Corporation does not currently pay a dividend according to our latest data.
- What exchange is INCY listed on?
- INCY is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Incyte Corporation in?
- Incyte Corporation is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →